Skip to main content
. 2019 Mar 25;19:267. doi: 10.1186/s12885-019-5480-0

Table 1.

Frequency, age specific incidence rates, average annual crude incidence rates and ASR by site in females in Kumasi, 2015

Site/Age group All Ages Age unkwnon 0 5 10 15–19 20–24 25–29 30–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75+ Crude Rate % Cum (0–64) CUM (0–74) ASR ICD
Lip 1 0 3.6 0.1 0.2 0.00 0.00 0.1 C00
Tongue 0 0 0.0 0.0 0.00 0.00 0.0 C01–02
Mouth 2 0 1.7 3.9 0.2 0.4 0.03 0.03 0.3 C03–06
Salivary glands 2 0 2.4 6.9 0.2 0.4 0.01 0.05 0.3 C07–08
Tonsil 1 0 2.2 0.1 0.2 0.01 0.01 0.1 C09
Other oropharynx 0 0 0.0 0.0 0.00 0.00 0.0 C10
Nasopharynx 2 0 0.7 1.7 0.2 0.4 0.01 0.01 0.2 C11
Hypopharynx 0 0 0.0 0.0 0.00 0.00 0.0 C12–13
Pharynx unspecified 0 0 0.0 0.0 0.00 0.00 0.0 C14
Oesophagus 0 0 0.0 0.0 0.00 0.00 0.0 C15
Stomach 14 0 4.4 2.4 27.6 20.7 3.6 1.1 2.8 0.04 0.30 1.8 C16
Small intestine 0 0 0.0 0.0 0.00 0.00 0.0 C17
Colon 8 0 1.4 3.4 8.3 13.8 5.2 0.7 1.8 0.07 0.16 1.1 C18
Rectum 4 0 1.4 2.2 4.1 3.6 0.3 0.9 0.04 0.04 0.5 C19–20
Anus 5 0 4.7 3.9 7.2 0.4 1.1 0.04 0.04 0.5 C21
Liver 28 0 0.7 1.7 2.8 2.4 4.2 3.4 2.2 4.7 11.8 4.1 27.6 15.5 3.6 2.3 6.1 0.19 0.41 3.2 C22
Gallbladder etc. 0 0 0.0 0.0 0.00 0.00 0.0 C23–24
Pancreas 3 0 2.4 3.9 4.1 0.2 0.7 0.05 0.05 0.4 C25
Nose, sinuses etc. 1 0 0.7 0.1 0.2 0.00 0.00 0.1 C30–31
Larynx 1 0 4.1 0.1 0.2 0.02 0.02 0.2 C32
Trachea, bronchus and lung 5 0 0.9 8.3 7.2 0.4 1.1 0.05 0.05 0.5 C33–34
Other thoracic organs 0 0 0.0 0.0 0.00 0.00 0.0 C37–38
Bone 4 0 1.9 1.4 4.1 0.3 0.9 0.04 0.04 0.4 C40–41
Melanoma of skin 1 0 3.6 0.1 0.2 0.00 0.00 0.1 C43
Other skin 2 0 1.7 6.9 0.2 0.4 0.01 0.04 0.3 C44
Mesothelioma 0 0 0.0 0.0 0.00 0.00 0.0 C45
Kaposi sarcoma 1 0 2.4 0.1 0.2 0.01 0.01 0.1 C46
Connective and soft tissue 6 0 0.7 1.6 2.2 3.9 4.1 0.5 1.3 0.06 0.06 0.7 C47,C49
Breast 138 0 2.6 1.9 9.5 14.0 30.4 50.1 56.8 63.1 41.4 34.5 20.7 46.8 11.3 30.0 1.36 1.64 16.1 C50
Vulva 3 0 3.9 4.1 3.6 0.2 0.7 0.04 0.04 0.4 C51
Vagina 0 0 0.0 0.0 0.00 0.00 0.0 C52
Cervix uteri 107 0 0.9 2.4 7.0 16.9 30.5 23.7 63.1 58.0 75.9 31.1 4.8 8.9 23.4 1.01 1.55 13.7 C53
Corpus uteri 10 0 1.2 7.9 8.3 13.8 15.5 0.8 2.2 0.09 0.23 1.4 C54
Uterus unspecified 4 0 7.1 3.9 0.3 0.9 0.06 0.06 0.5 C55
Ovary 29 0 0.9 1.9 4.7 1.4 5.1 4.4 11.8 7.9 27.6 5.2 4.4 2.4 6.3 0.19 0.35 3.3 C56
Other female genital organs 0 0 0.0 0.0 0.00 0.00 0.0 C57
Placenta 5 0 1.7 0.9 1.2 1.7 0.4 1.1 0.03 0.03 0.4 C58
Kidney 4 0 0.6 0.8 0.9 2.4 0.3 0.9 0.02 0.02 0.3 C64
Renal pelvis 0 0 0.0 0.0 0.00 0.00 0.0 C65
Ureter 0 0 0.0 0.0 0.00 0.00 0.0 C66
Bladder 11 0 1.7 4.7 7.9 4.1 6.9 5.2 0.8 0.9 2.4 0.09 0.15 1.3 C67
Other urinary organs 0 0 0.0 0.0 0.00 0.00 0.0 C68
Eye 3 0 1.9 0.2 0.7 0.01 0.01 0.2 C69
Brain, nervous system 7 0 0.7 0.8 0.9 4.2 1.7 0.6 1.5 0.04 0.04 0.6 C70–72
Thyroid 3 0 3.9 4.1 5.2 0.2 0.7 0.04 0.07 0.4 C73
Adrenal gland 0 0 0.0 0.0 0.00 0.00 0.0 C74
Other endocrine 0 0 0.0 0.0 0.00 0.00 0.0 C75
Hodgkin disease 4 0 0.7 0.9 2.2 3.6 0.3 0.9 0.02 0.02 0.3 C81
Non-Hodgkin lymphoma 21 0 0.6 0.7 0.7 1.6 0.9 1.2 2.8 6.8 2.2 4.7 8.3 10.8 1.7 4.6 0.15 0.15 2.0 C82–85,C96
Immunoproliferative diseases 0 0 0.0 0.0 0.00 0.00 0.0 C88
Multiple myeloma 3 0 3.9 10.4 0.2 0.7 0.02 0.07 0.4 C90
Lymphoid leukaemia 3 0 0.6 0.7 0.9 0.2 0.7 0.01 0.01 0.2 C91
Myeloid leukaemia 7 0 1.2 0.7 3.4 7.9 0.6 1.5 0.07 0.07 0.7 C92–94
Leukaemia unspecified 0 0 0.0 0.0 0.00 0.00 0.0 C95
Myeloproliferative disorders 0 0 0.0 0.0 0.00 0.00 0.0 MPD
Myelodysplastic syndromes 0 0 0.0 0.0 0.00 0.00 0.0 MDS
Other and unspecified 8 0 0.8 1.9 2.2 4.7 4.1 3.6 0.7 1.8 0.07 0.07 0.8 O&U
All sites 459 0 5.0 2.0 5.1 5.6 8.5 16.0 22.5 37.9 79.5 104.6 134.9 201.2 174.0 241.6 134.6 90.9 38.0 4.00 5.89 54.1 ALL
All sites but C44 457 0 5.0 2.0 5.1 5.6 8.5 16.0 22.5 37.9 77.8 104.6 134.9 201.2 174.0 234.7 134.6 190.9 37.9 100.0 3.99 5.85 53.8 ALLbC44

Reference population: world standard PopulationTable builtTue Apr 18 17:19:48 UTC 2017 by CanReg5